Cargando…

Potential therapeutic effect of nanobased formulation of rivastigmine on rat model of Alzheimer’s disease

BACKGROUND: To sustain the effect of rivastigmine, a hydrophilic cholinesterase inhibitor, nanobased formulations were prepared. The efficacy of the prepared rivastigmine liposomes (RLs) in comparison to rivastigmine solution (RS) was assessed in an aluminium chloride (AlCl(3))-induced Alzheimer’s m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ismail, Manal Fouad, ElMeshad, Aliaa Nabil, Salem, Neveen Abdel-Hameed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3558309/ https://www.ncbi.nlm.nih.gov/pubmed/23378761 http://dx.doi.org/10.2147/IJN.S39232

Ejemplares similares

Hybrid chitosan-lipid nanoparticles of green tea extract as natural anti-cellulite agent with superior in vivo potency: full synthesis and analysis
por: Abosabaa, Sara A., et al.
Publicado: (2021)

Enhancement of dissolution and oral bioavailability of lacidipine via pluronic P123/F127 mixed polymeric micelles: formulation, optimization using central composite design and in vivo bioavailability study
por: Fares, Ahmed R., et al.
Publicado: (2017)

Green Synthesized Honokiol Transfersomes Relieve the Immunosuppressive and Stem-Like Cell Characteristics of the Aggressive B16F10 Melanoma
por: Ezzeldeen, Yasmeen, et al.
Publicado: (2021)

Chitosan Nanocarrier Entrapping Hydrophilic Drugs as Advanced Polymeric System for Dual Pharmaceutical and Cosmeceutical Application: A Comprehensive Analysis Using Box-Behnken Design
por: Abosabaa, Sara A., et al.
Publicado: (2021)

Zein/Phospholipid Composite Nanoparticles for Successful Delivery of Gallic Acid into aHSCs: Influence of Size, Surface Charge, and Vitamin A Coupling
por: Radwan, Shaimaa Ali Ali, et al.
Publicado: (2020)

Distinct Proteins in Protein Corona of Nanoparticles Represent a Promising Venue for Endogenous Targeting – Part I: In vitro Release and Intracellular Uptake Perspective
por: Sebak, Aya Ahmed, et al.
Publicado: (2020)

Distinct Proteins in Protein Corona of Nanoparticles Represent a Promising Venue for Endogenous Targeting – Part II: In vitro and in vivo Kinetics Study
por: Sebak, Aya Ahmed, et al.
Publicado: (2020)

Development and Pre-Clinical Evaluation of Recombinant Human Myelin Basic Protein Nano Therapeutic Vaccine in Experimental Autoimmune Encephalomyelitis Mice Animal Model
por: Al-Ghobashy, Medhat A., et al.
Publicado: (2017)

Nanobase.org: a repository for DNA and RNA nanostructures
por: Poppleton, Erik, et al.
Publicado: (2021)

PLGA/PEG Nanoparticles Loaded with Cyclodextrin-Peganum harmala Alkaloid Complex and Ascorbic Acid with Promising Antimicrobial Activities
por: Fahmy, Sherif Ashraf, et al.
Publicado: (2022)

Different Curcumin-Loaded Delivery Systems for Wound Healing Applications: A Comprehensive Review
por: Sideek, Sarah A., et al.
Publicado: (2022)

Rivastigmine in the treatment of Alzheimer’s disease: an update
por: Onor, Maria Luisa, et al.
Publicado: (2007)

Rivastigmine in the treatment of patients with Alzheimer’s disease
por: Müller, Thomas
Publicado: (2007)

Nanobased Platforms for Diagnosis and Treatment of COVID-19: From Benchtop to Bedside
por: Bidram, Elham, et al.
Publicado: (2021)

Development and Validation of a Spectrofluorimetric Method for the Estimation of Rivastigmine in Formulations
por: Kapil, R., et al.
Publicado: (2009)

Delineating a potent antiviral activity of Cuphea ignea extract loaded nano-formulation against SARS-CoV-2: In silico and in vitro studies
por: Mahmoud, Dina B., et al.
Publicado: (2021)

The effect of nanobased irrigants on the root canal dentin microhardness: an ex-vivo study
por: Sahebi, Safoora, et al.
Publicado: (2023)

Neural stem cells for Parkinson’s disease management: Challenges, nanobased support, and prospects
por: Oz, Tuba, et al.
Publicado: (2023)

Pharmacokinetic and pharmacodynamic evaluation of nasal liposome and nanoparticle based rivastigmine formulations in acute and chronic models of Alzheimer’s disease
por: Rompicherla, Sampath Kumar L., et al.
Publicado: (2021)

Rivastigmine in Alzheimer’s disease: Cognitive function and quality of life
por: Annicchiarico, Roberta, et al.
Publicado: (2007)

Once-daily transdermal rivastigmine in the treatment of Alzheimer’s disease
por: Wentrup, Andreas, et al.
Publicado: (2009)

Rivastigmine modifies the α-secretase pathway and potentially early Alzheimer’s disease
por: Ray, Balmiki, et al.
Publicado: (2020)

GLUT1 and GLUT3 involvement in anthocyanin gastric transport- Nanobased targeted approach
por: Oliveira, Hélder, et al.
Publicado: (2019)

A Combinatorial Nanobased Spray-Induced Gene Silencing Technique for Crop Protection and Improvement
por: Ghosh, Snigdha, et al.
Publicado: (2023)

The transdermal formulation of rivastigmine improves caregiver burden and treatment adherence of patients with Alzheimer's disease under daily practice conditions
por: Adler, G, et al.
Publicado: (2014)

Influence of Rivastigmine transdermal on butyrylcholinesterase levels in patients with Alzheimer's disease
por: dos Santos, Gustavo Alves Andrade, et al.
Publicado: (2011)

Correction: Rivastigmine modifies the α-secretase pathway and potentially early Alzheimer’s disease
por: Ray, Balmiki, et al.
Publicado: (2020)

Efficacy of rivastigmine transdermal therapy on low food intake in patients with Alzheimer's disease: The Attitude Towards Food Consumption in Alzheimer's Disease Patients Revive with Rivastigmine Effects study
por: Tsuno, Norifumi, et al.
Publicado: (2019)

Esophagectasis Related to Rivastigmine
por: Sasaki, Osamu, et al.
Publicado: (2019)

Effectiveness and tolerability of transdermal rivastigmine in the treatment of Alzheimer’s disease in daily practice
por: Seibert, Johannes, et al.
Publicado: (2012)

Rivastigmine improves dual-task gait velocity in patients with Alzheimer’s disease
por: Shimura, Hideki, et al.
Publicado: (2021)

Comparative study of rivastigmine and galantamine on the transgenic Drosophila model of Alzheimer's disease
por: Siddique, Yasir Hasan, et al.
Publicado: (2022)

Rivastigmine-Loaded L-Lactide-Depsipeptide Polymeric Nanoparticles: Decisive Formulation Variable Optimization
por: Pagar, Kunal, et al.
Publicado: (2013)

QbD-based rivastigmine tartrate-loaded solid lipid nanoparticles for enhanced intranasal delivery to the brain for Alzheimer's therapeutics
por: Arora, Deepshi, et al.
Publicado: (2022)

Novel Rivastigmine Derivatives as Promising Multi-Target Compounds for Potential Treatment of Alzheimer’s Disease
por: Vicente-Zurdo, David, et al.
Publicado: (2022)

Development of a Simple, Fast, and Cost-Effective Nanobased Immunoassay Method for Detecting Norovirus in Food Samples
por: Alhadrami, Hani A., et al.
Publicado: (2020)

Domperidone effective in preventing rivastigmine-related gastrointestinal disturbances in patients with Alzheimer’s disease
por: Kano, Osamu, et al.
Publicado: (2013)

The Effect of Rivastigmine Transdermal Patch on Sleep Apnea in Patients with Probable Alzheimer's Disease
por: Kim, Hyeyun, et al.
Publicado: (2016)

Effects of Renal Impairment on Steady-State Plasma Concentrations of Rivastigmine: A Population Pharmacokinetic Analysis of Capsule and Patch Formulations in Patients with Alzheimer’s Disease
por: Lefèvre, Gilbert, et al.
Publicado: (2016)

Nanoformulated Recombinant Human Myelin Basic Protein and Rituximab Modulate Neuronal Perturbations in Experimental Autoimmune Encephalomyelitis in Mice
por: Saad, Muhammed A, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sksa9u8ihtbs7e0k4004u0r13s